News
-
-
-
-
-
PRESS RELEASE
Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases
Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases. Afqlir® matches reference medicine in efficacy, safety, and pharmacokinetics, reinforcing Sandoz commitment to patient access -
-
REGULATED PRESS RELEASE
Entrée en négociations exclusives pour Novacel
Compagnie Chargeurs Invest annonce des négociations exclusives pour la cession de Novacel avec KPS Capital Partners, visant une collaboration stratégique et financière. Projet de transaction en numéraire pour renforcer les fonds propres et accélérer le développement -
-
-
PRESS RELEASE
BNP PARIBAS LAUNCHES A SHARE BUYBACK PROGRAMME OF EUR 1.15 BILLION FOR THE 2025 FINANCIAL YEAR RESULTS
BNP Paribas launches a share buyback program of EUR 1.15 billion for the 2025 financial year results. The program follows approval from the European Central Bank, aims to repurchase shares for various purposes as outlined in the press release